Warning: This security is no longer trading.
Sanofi completes deal to acquire Ablynx NV
Ablynx NV (ABLX): Price and Financial Metrics
ABLX Price/Volume Stats
| Current price | $52.87 | 52-week high | $55.29 |
| Prev. close | $52.76 | 52-week low | $17.75 |
| Day low | $52.80 | Volume | 14,500 |
| Day high | $53.15 | Avg. volume | 249,005 |
| 50-day MA | $53.70 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | N/A |
ABLX Stock Price Chart Interactive Chart >
Ablynx NV (ABLX) Company Bio
Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, immuno-oncology, oncology, and respiratory diseases. The company was founded in 2001 and is based in Ghent, Belgium.
ABLX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...